InnoCan Pharma (TSE:INNO) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InnoCan Pharma has successfully closed a private placement, raising C$635,444.60 through the issuance of 3,177,223 units. The funds will be used to advance its CBD-loaded liposome platform technology and support consumer wellness operations. This move signals strong investor confidence in the company’s strategic direction and innovative offerings.
For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.